These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33888263)

  • 21. Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report.
    Puram VV; Ghazaleh D; Salari A; McCleary K; Moriarty G; Nichols K; Ghannam M; Brown K; Berry B
    BMC Neurol; 2022 Aug; 22(1):318. PubMed ID: 36008800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
    Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
    Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.
    Egoryan G; Murguia-Fuentes R; Agab M; Abou-Ghanem N; Yanez-Bello MA; Pyakuryal B; Trelles-Garcia DP; Ibrahim R; Filipiuk D; Gidron A; Rodriguez-Nava G
    J Med Case Rep; 2021 Apr; 15(1):161. PubMed ID: 33840384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.
    Gil I; Serrazina F; Pinto M; Viana-Baptista M
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32066575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome.
    Kwon EJ; Kim SW; Kim KK; Seo HS; Kim DY
    Cancer Res Treat; 2009 Mar; 41(1):53-5. PubMed ID: 19688073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior Reversible Encephalopathy Syndrome Occurred During the Use of Pseudoephedrine: A Case Report.
    Gunduz ZB
    Clin Neuropharmacol; 2022 Sep-Oct 01; 45(5):145-147. PubMed ID: 36066857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review.
    Barba L; Carrubba C; Spindler K; Weise CM; Sachs T; Foschi M; D'Anna L; Sehm B; Ibe R; Elolf E; Strauss C; Otto M; Mensch A; Abu-Rumeileh S
    Neurol Sci; 2024 Sep; 45(9):4151-4159. PubMed ID: 38679625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior reversible encephalopathy syndrome following coronary angiography.
    Paul A; Bhaumik S; Das SS; Das US; Pramanick G; Banerjee S
    J R Coll Physicians Edinb; 2022 Dec; 52(4):324-326. PubMed ID: 36476109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemisphere lesions: A case report.
    Liu L; Dai D; Cao F; Zhang L; Wang X
    Medicine (Baltimore); 2019 Jan; 98(2):e13649. PubMed ID: 30633153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).
    Janjua TK; Hassan M; Afridi HK; Zahid NA
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior reversible encephalopathy syndrome (PRES) after combination chemotherapy for lymphoma.
    Ramachandran A; Klein R
    Am J Ther; 2014; 21(5):e137-42. PubMed ID: 23075577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior reversible encephalopathy syndrome (PRES) associated with liquorice consumption.
    O'Connell K; Kinsella J; McMahon C; Holian J; O'Riordan S
    Ir J Med Sci; 2016 Nov; 185(4):945-947. PubMed ID: 25342161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal cholestatic liver failure associated with gemcitabine therapy.
    Robinson K; Lambiase L; Li J; Monteiro C; Schiff M
    Dig Dis Sci; 2003 Sep; 48(9):1804-8. PubMed ID: 14561005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanib.
    Tatsumichi T; Tanaka H; Okazaki T; Takahashi K; Suzuki K; Kawakita K; Houchi H; Kuroda Y; Kosaka S
    J Clin Pharm Ther; 2021 Feb; 46(1):223-226. PubMed ID: 33044009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GEMCITABINE-INDUCED RETINOPATHY.
    Kovach JL
    Retin Cases Brief Rep; 2018 Summer; 12(3):240-241. PubMed ID: 27806002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome.
    Faille LD; Fieuws S; Van Paesschen W
    Acta Neurol Belg; 2017 Jun; 117(2):469-475. PubMed ID: 28144796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
    Tetsuka S; Nonaka H
    BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first two cases of posterior reversible encephalopathy syndrome (PRES) secondary to conventional transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Jia K; Yin W; Wang F; Gao Z; Sun C; Wang H; Han Y; Wang Y; Li M; Yu C
    BMC Gastroenterol; 2021 Dec; 21(1):492. PubMed ID: 34930135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case of posterior reversible encephalopathy syndrome caused by Fisher syndrome].
    Yokoi K; Ando T; Kawakami O
    Rinsho Shinkeigaku; 2018 Jan; 58(1):45-48. PubMed ID: 29269696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posterior Reversible Encephalopathy Syndrome During Combined Modality Therapy for Head and Neck Squamous Cell Carcinoma.
    Wakasaki T; Gotoh S; Tomonobe E; Mihara T; Fukushima J
    Ann Otol Rhinol Laryngol; 2016 Oct; 125(10):844-9. PubMed ID: 27317313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.